AndrewAaronMuskovitzMD

Oncology • Sterling Heights, MI

Hematologic Oncology

Assistant Professor

Join to view full profile

Dr. Muskovitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Muskovitz's full profile

Already have an account?

Office
44344 Dequindre
suite 260
Sterling Heights, MI 48314
Phone+1 586-323-1500

Fax+1 586-323-1515

Summary

Dr. Muskovitz is a graduate of Wayne State University School of Medicine, class of 2005. He completed Internal Medicine residency and Geriatric fellowship training at University of Illinois
Chicago, followed by Oncology and Hematology training at Karmanos. He practices general Medical Oncology and Hematology with the Cancer and Leukemia Center at Troy Beaumont, having joined the Troy medical staff in 2015 and Royal Oak in 2012. He has a clinical interest in caring for older adults with cancer problems and is one of a small number of physicians in the US who are dual certified in Geriatric Medicine and Oncology. Dr. Muskovitz assumed Medical Directorship of the Cancer Clinical Trial Office at Beaumont Health in August 2020.

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Illinois College of Medicine at ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2008 - 2009
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
Wayne State University School of MedicineClass of 2005

Certifications & Licensure

MI State Medical License 2009 - 2027
IL State Medical License 2005 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma Start of enrollment: 2012 Nov 01
Active, not recruiting
Phase 1, Phase 2
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer Start of enrollment: 2014 Apr 22
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

75 citations
Estrogen plus progestin and colorectal cancer incidence and mortality.
Michael S. Simon, Rowan T. Chlebowski, Jean Wactawski-Wende, Karen C. Johnson, Andrew A. Muskovitz
Journal of Clinical Oncology. 2012-11-10
14 citations
Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome.
Ron C. Gaba, Rajesh Shah, Andrew A. Muskovitz, Grace Guzman, Edward A. Michals
Journal of Clinical Neuroscience. 2008-12-01
SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
Virginia Sun, Katherine A Guthrie, Tracy E Crane, Kathryn B Arnold, Sarah Colby
Cancer. 2024-07-01